Kisho

Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy

acute intermittent porphyria News | Kisho

Kisho

Not rare diseases news,
news about your rare disease.

Earlier

A case report highlights acute intermittent porphyria presenting with severe complications including rhabdomyolysis, polyneuropathy, quadriparesis, and respiratory failure. This case underscores the need for awareness and understanding of the disease's severe manifestations.

The International Porphyria Network has released updated guidelines for managing acute porphyria, aiming to standardize treatment approaches. These recommendations are crucial for improving patient outcomes and ensuring consistent care across healthcare providers.

A case report highlights severe peripheral neuropathy linked to acute intermittent porphyria due to a rare HMBS gene mutation. This discovery adds to the understanding of the genetic factors contributing to this rare disease.

A recent study published in PubMed highlights the clinical characteristics and outcomes of acute intermittent porphyria, utilizing data from the European Porphyria Registry. This research provides valuable insights into the disease's impact on patients and may inform future treatment strategies.

Not rare diseases news,news about your rare disease.

Earlier

A case report highlights acute intermittent porphyria presenting with severe complications including rhabdomyolysis, polyneuropathy, quadriparesis, and respiratory failure. This case underscores the need for awareness and understanding of the disease's severe manifestations.

The International Porphyria Network has released updated guidelines for managing acute porphyria, aiming to standardize treatment approaches. These recommendations are crucial for improving patient outcomes and ensuring consistent care across healthcare providers.

A case report highlights severe peripheral neuropathy linked to acute intermittent porphyria due to a rare HMBS gene mutation. This discovery adds to the understanding of the genetic factors contributing to this rare disease.

A recent study published in PubMed highlights the clinical characteristics and outcomes of acute intermittent porphyria, utilizing data from the European Porphyria Registry. This research provides valuable insights into the disease's impact on patients and may inform future treatment strategies.

Not rare diseases news,
news about your rare disease.